BREAST SCANNING

Breast Scanning with DITI (Digital Infrared Thermal Imaging) is:

  • non invasive
  • has no radiation
  • is painless
  • has no contact with the body
  • FDA approved
  • Scans are done by ACCT qualified Thermographer
  • Interpretation done by a panel of 39 board certified medical doctors in the USA
  • Reports done within 3 days.

As you all know that have been here before our DITI is done by our professional practitioner
Mr.Albert Michau and for more information on this process see www.thermalmed.co.za

For bookings kindly call B Healthy on 021 887 3442 or send us an email at: bhealthy.cape@gmail.com

A Review of Breast Thermography

Note: The following is not a comprehensive review of the literature. Over 30 years of research compiling over 800 studies in the index-medicus exist. What follows is a pertinent sample review of the research concerning the clinical application of diagnostic infrared imaging (thermography) for use in breast cancer screening. All the citations are taken from the index-medicus peer-reviewed research literature or medical textbooks. The authors are either PhD’s with their doctorate in a representative fi eld, or physicians primarily in the specialties of oncology, radiology, gynaecology, and internal medicine.

The following list is a summary of the informational text that follows:

  • In 1982, the FDA approved breast thermography as an adjunctive diagnostic breast cancer screening procedure.
  • Breast thermography has undergone extensive research since the late 1950’s.
  • Over 800 peer-reviewed studies on breast thermography exist in the index-medicus literature.
  • In this database, well over 300,000 women have been included as study participants.
  • The numbers of participants in many studies are very large -- 10K, 37K, 60K.
  • Some of these studies have followed patients up to 12 years.
  • Strict standardized interpretation protocols have been established for over 15 years.
  • Breast thermography has an average sensitivity and specificity of 90%.
  • An abnormal thermogram is 10 times more significant as a future risk indicator for breast cancer than a first order family history of the disease.
  • A persistent abnormal thermogram caries with it a 22x higher risk of future breast cancer.
  • An abnormal infrared image is the single most important marker of high risk for developing breast cancer.
  • Breast thermography has the ability to detect the first signs that a cancer may be forming up to 10 years before any other procedure can detect it.
  • Extensive clinical trials have shown that breast thermography significantly augments the long-term survival rates of its recipients by as much as 61%.
  • When used as part of a multimodal approach (clinical examination + mammography + thermography) 95% of early stage cancers will be detected.